Christopher Bloomstran
Semper Augustus Investments Group
Semper Augustus Investments Group Portfolio 13F
Christopher Bloomstran Holdings Activity
- Portfolio value:
- $134.84M~ (-$3M~)
- Previous value:
- $137.86M~
- # of changes:
- 20
- New positions:
- 0
- Reported for:
- 31 Dec 2016 (Q4)
- Latest filing date:
- 13 Feb 2017
Semper Augustus Investments Group has disclosed a total of 20 changes to the portfolio in the (2016 Q4) SEC report(s): increased the number of shares of 1, decreased the number of shares of 17 and completely sold out 2 position(s).
What stocks did Christopher Bloomstran buy in 2016 Q4?
During 2016 Q4 Christopher Bloomstran has bought (GG) Goldcorp Inc (added shares +18.68%).
What did Christopher Bloomstran invest in during 2016 Q4?
In the 2016 Q4 report(s) the following changes have been made to the top investments: (BRK-B) Berkshire Hathaway Inc (reduced shares -2.47%), (XOM-OLD) Exxon Mobil Corp (reduced shares -0.37%), (LUK) Leucadia National Corp (reduced shares -0.12%) and (NEM) Newmont Goldcorp Corp (reduced shares -0.20%).
20 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Goldcorp Inc
|
+18.68%
|
$13.60
|
|
4.47%
|
2013 Q2*
|
> 3 years
|
||||
|
|
American Express Company
|
-0.07%
|
$74.09
|
+339.05%($325.27)
|
1.99%
|
2015 Q1
|
~2.00 years
|
||||
|
|
Equinor ASA ADR
|
-0.08%
|
$18.24
|
+141.14%($43.98)
|
1.72%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Intel Corp
|
-0.11%
|
$36.27
|
+144.20%($88.56)
|
2.34%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Leucadia National Corp
|
-0.12%
|
$23.25
|
|
5.25%
|
2013 Q2*
|
> 3 years
|
||||
|
|
AVX CORP
|
-0.13%
|
$15.63
|
|
2.59%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Johnson & Johnson
|
-0.13%
|
$115.20
|
+134.44%($270.08)
|
1.70%
|
2013 Q2*
|
> 3 years
|
||||
|
|
CNA Financial Corp
|
-0.13%
|
$41.49
|
+16.71%($48.42)
|
1.15%
|
2013 Q2*
|
> 3 years
|
||||
|
|
Hexcel Corp
|
-0.15%
|
$51.44
|
+80.31%($92.74)
|
3.16%
|
2016 Q2
|
~0.75 years
|
||||
|
|
Sanofi ADR
|
-0.16%
|
$40.44
|
+9.92%($44.46)
|
3.17%
|
2013 Q2*
|
> 3 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".